Private Grant  awarded by ORTHO-MCNEIL, INC.

Private Grant  awarded by Janssen

2/2- Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression  awarded by National Institute of Mental Health/NIH/DHHS

2/4-A Genomic Approach to Schizophrenia  awarded by National Institute of Mental Health/NIH/DHHS

A Feasibility Trial of Esketamine Plus Cognitive Behavioral Therapy for Patients with Major Depressive Disorder Who are Hospitalized for Suicidal Ideation  awarded by Yale University

A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease (“Protocol”).  awarded by Washington University

A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease  awarded by Washington University

A Placebo-Controlled, Crossover Study of Fanapt® (iloperidone) Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL

AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer’s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer’s Disease and Intermediate Amyloid (A3 Trial)  awarded by University of Southern California

Alzehimer's Disease Neuroimaging Initiative (ADNI)  awarded by University of California, San Diego

Alzheimer's Disease Cooperative Study  awarded by University of California, San Diego

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)  awarded by University of Southern California

Alzheimer's Disease Neuroimaging Initiative 3 (ADNl3)  awarded by University of Southern California

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study  awarded by University of Southern California

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)  awarded by University of Southern California

Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders with Treatment Resistant Depression (ASCERTAIN-TRD)  awarded by PARTNERS HEALTHCARE

Balanced Placebo Design with Varenicline: Pharmacological and Expectancy Effects on Medication Adherence  awarded by National Institute on Drug Abuse/NIH/DHHS

Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease  awarded by University of Southern California

Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL

Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)  awarded by MASSACHUSETTS GENERAL HOSPITAL

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - The LEARN Study A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of California, San Diego

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of Southern California

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation  awarded by American Foundation for Suicide Prevention

Private Grant  awarded by JANSSEN AI (ALZHEIMER IMMUNOTHERAPY) R&D

Private Grant  awarded by Pfizer Pharmaceuticals

Private Grant  awarded by Pfizer Pharmaceuticals

Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER

Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC

Private Grant  awarded by NAUREX, INC.

Private Grant  awarded by Elan

Private Grant  awarded by TAL MEDICAL

Private Grant  awarded by INNOPHARMA, INC.

Private Grant  awarded by EISAI, INC.

Private Grant  awarded by H. LUNDBECK A/S

Private Grant  awarded by CERECOR, INC.

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by ASSUREX HEALTH INC.

Private Grant  awarded by H. LUNDBECK A/S

Private Grant  awarded by AVANIR PHARMACEUTICALS, INC.

Private Grant  awarded by ALKERMES, INC.

Private Grant  awarded by ALKERMES, INC.

Private Grant  awarded by NAUREX, INC.

Private Grant  awarded by FOREST LABORATORIES, INC.

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by BIOGEN, INC.

Private Grant  awarded by GENOMIND

Private Grant  awarded by ALLERGAN, INC.

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by Janssen

Private Grant  awarded by Janssen

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by ACADIA PHARMACEUTICALS, INC.

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by ALLERGAN SALES, LLC

Private Grant  awarded by ALLERGAN SALES, LLC

Private Grant  awarded by ALLERGAN SALES, LLC

Private Grant  awarded by NEURORX

Private Grant  awarded by INTRA-CELLULAR THERAPIES INC.

Private Grant  awarded by ALLERGAN, INC.

Private Grant  awarded by BIOGEN, INC.

Private Grant  awarded by BIOGEN MA INC

Private Grant  awarded by Genentech

Private Grant  awarded by ALLERGAN, INC.

Private Grant  awarded by NAVITOR PHARMACEUTICALS INC.

Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION - NEW

Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC

Private Grant  awarded by ACADIA PHARMACEUTICALS, INC.

Private Grant  awarded by NEURORX

Private Grant  awarded by CTI BIOPHARMA CORP

Private Grant  awarded by NEURORX

Private Grant  awarded by ACADIA PHARMACEUTICALS, INC.

Private Grant  awarded by BIOGEN MA INC

Private Grant  awarded by LIVANOVA USA, INC.

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^

Private Grant  awarded by AVANIR PHARMACEUTICALS, INC.

Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC

Private Grant  awarded by LIVANOVA USA, INC.

Private Grant  awarded by NEUROCRINE BIOSCIENCES INC

Private Grant  awarded by MERCK SHARP & DOHME CORP

Private Grant  awarded by NEUROCRINE BIOSCIENCES INC

The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease  awarded by University of Southern California

UAB Alzheimer's Disease Research Center  awarded by National Institute on Aging/NIH/DHHS